173 related articles for article (PubMed ID: 38611022)
1. The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer.
Campanelli G; Francois E; Parupathi P; Devarakonda LS; Yang C; Kumar A; Levenson AS
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611022
[TBL] [Abstract][Full Text] [Related]
2. Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer.
Parupathi P; Campanelli G; Deabel RA; Puaar A; Devarakonda LS; Kumar A; Levenson AS
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551523
[TBL] [Abstract][Full Text] [Related]
3. MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
Kumar A; Dholakia K; Sikorska G; Martinez LA; Levenson AS
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487842
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study.
Gadkari K; Kolhatkar U; Hemani R; Campanelli G; Cai Q; Kumar A; Levenson AS
Nutrients; 2020 Nov; 12(12):. PubMed ID: 33255879
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
Levenson AS
Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
[TBL] [Abstract][Full Text] [Related]
6. Molecular Efficacy of Gnetin C as Dual-Targeted Therapy for Castrate-Resistant Prostate Cancer.
Campanelli G; Deabel RA; Puaar A; Devarakonda LS; Parupathi P; Zhang J; Waxner N; Yang C; Kumar A; Levenson AS
Mol Nutr Food Res; 2023 Dec; 67(24):e2300479. PubMed ID: 37863824
[TBL] [Abstract][Full Text] [Related]
7. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
8. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
[TBL] [Abstract][Full Text] [Related]
9. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
[TBL] [Abstract][Full Text] [Related]
11. Dietary stilbenes as modulators of specific miRNAs in prostate cancer.
Levenson AS
Front Pharmacol; 2022; 13():970280. PubMed ID: 36091792
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Gnetin C from Melinjo Seed Extract against High-Fat Diet-Induced Hepatic Steatosis and Liver Fibrosis in NAFLD Mice Model.
Kabir T; Yoshiba H; Agista AZ; Sultana H; Ohsaki Y; Yeh CL; Hirakawa R; Tani H; Ikuta T; Nochi T; Yang SC; Shirakawa H
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764672
[TBL] [Abstract][Full Text] [Related]
13. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
[TBL] [Abstract][Full Text] [Related]
14. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
Kumar A; D'silva M; Dholakia K; Levenson AS
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463302
[TBL] [Abstract][Full Text] [Related]
18. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
Levenson AS; Kumar A; Zhang X
Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of gnetin C, a resveratrol dimer from melinjo (Gnetum gnemon), on tyrosinase activity and melanin biosynthesis.
Yanagihara M; Yoshimatsu M; Inoue A; Kanno T; Tatefuji T; Hashimoto K
Biol Pharm Bull; 2012; 35(6):993-6. PubMed ID: 22687546
[TBL] [Abstract][Full Text] [Related]
20. A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells.
Morad SA; Schmid M; Büchele B; Siehl HU; El Gafaary M; Lunov O; Syrovets T; Simmet T
Mol Pharmacol; 2013 Feb; 83(2):531-41. PubMed ID: 23208958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
